Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2014

Open Access 01-12-2014 | Research article

Phenotype, origin and estimated prevalence of a common long QT syndrome mutation: a clinical, genealogical and molecular genetics study including Swedish R518X/KCNQ1families

Authors: Annika Winbo, Eva-Lena Stattin, Charlotte Nordin, Ulla-Britt Diamant, Johan Persson, Steen M Jensen, Annika Rydberg

Published in: BMC Cardiovascular Disorders | Issue 1/2014

Login to get access

Abstract

Background

The R518X/KCNQ1 mutation is a common cause of autosomal recessive (Jervell and Lange Nielsen Syndrome- JLNS) and autosomal dominant long QT syndrome (LQTS) worldwide. In Sweden p.R518X accounts for the majority of JLNS cases and is the second most common cause of LQTS. Here we investigate the clinical phenotype and origin of Swedish carriers of the p.R518X mutation.

Methods

The study included 19 Swedish p.R518X index families, ascertained by molecular genetics methods (101 mutation-carriers, whereof 15 JLNS cases and 86 LQTS cases). In all families analyses included assessment of clinical data (symptoms, medications and manually measured electrocardiograms), genealogy (census records), haplotype (microsatellite markers) as well as assessment of mutation age and associated prevalence (ESTIAGE and DMLE computer software).

Results

Clinical phenotype ranged from expectedly severe in JLNS to surprisingly benign in LQTS (QTc 576 ± 61 ms vs. 462 ± 34 ms, cumulative incidence of (aborted) cardiac arrest 47% vs. 1%, annual non-medicated incidence rate (aborted) cardiac arrest 4% vs. 0.04%).
A common northern origin was found for 1701/1929 ancestors born 1650-1950. Historical geographical clustering in the coastal area of the Pite River valley was shown. A shared haplotype spanning the KCNQ1 gene was seen in 17/19 families. Mutation age was estimated to 28 generations (95% CI 19;41). A high prevalence of Swedish p.R518X heterozygotes was suggested (~1:2000-4000).

Conclusions

R518X/KCNQ1 occurs as a common founder mutation in Sweden and is associated with an unexpectedly benign phenotype in heterozygous carriers.
Appendix
Available only for authorised users
Literature
1.
go back to reference Shimizu W, Horie M: Phenotypic manifestations of mutations in genes encoding subunits of cardiac potassium channels. Circ Res. 2011, 109 (1): 97-109. 10.1161/CIRCRESAHA.110.224600.CrossRefPubMed Shimizu W, Horie M: Phenotypic manifestations of mutations in genes encoding subunits of cardiac potassium channels. Circ Res. 2011, 109 (1): 97-109. 10.1161/CIRCRESAHA.110.224600.CrossRefPubMed
2.
go back to reference Kapplinger JD, Tester DJ, Salisbury BA, Carr JL, Harris-Kerr C, Pollevick GD, Wilde AA, Ackerman MJ: Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm. 2009, 6 (9): 1297-1303. 10.1016/j.hrthm.2009.05.021.CrossRefPubMedPubMedCentral Kapplinger JD, Tester DJ, Salisbury BA, Carr JL, Harris-Kerr C, Pollevick GD, Wilde AA, Ackerman MJ: Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm. 2009, 6 (9): 1297-1303. 10.1016/j.hrthm.2009.05.021.CrossRefPubMedPubMedCentral
3.
go back to reference Stattin EL, Bostrom IM, Winbo A, Cederquist K, Jonasson J, Jonsson BA, Diamant UB, Jensen SM, Rydberg A, Norberg A: Founder mutations characterise the mutation panorama in 200 Swedish index cases referred for Long QT syndrome genetic testing. BMC Cardiovasc Disord. 2012, 12 (1): 95-10.1186/1471-2261-12-95.CrossRefPubMedPubMedCentral Stattin EL, Bostrom IM, Winbo A, Cederquist K, Jonasson J, Jonsson BA, Diamant UB, Jensen SM, Rydberg A, Norberg A: Founder mutations characterise the mutation panorama in 200 Swedish index cases referred for Long QT syndrome genetic testing. BMC Cardiovasc Disord. 2012, 12 (1): 95-10.1186/1471-2261-12-95.CrossRefPubMedPubMedCentral
4.
go back to reference Winbo A, Stattin EL, Diamant UB, Persson J, Jensen SM, Rydberg A: Prevalence, mutation spectrum, and cardiac phenotype of the Jervell and Lange-Nielsen syndrome in Sweden. Europace. 2012, 14 (12): 1799-1806. 10.1093/europace/eus111.CrossRefPubMed Winbo A, Stattin EL, Diamant UB, Persson J, Jensen SM, Rydberg A: Prevalence, mutation spectrum, and cardiac phenotype of the Jervell and Lange-Nielsen syndrome in Sweden. Europace. 2012, 14 (12): 1799-1806. 10.1093/europace/eus111.CrossRefPubMed
5.
go back to reference Winbo A, Diamant UB, Rydberg A, Persson J, Jensen SM, Stattin EL: Origin of the Swedish long QT syndrome Y111C/KCNQ1 founder mutation. Heart Rhythm. 2011, 8 (4): 541-547. 10.1016/j.hrthm.2010.11.043.CrossRefPubMed Winbo A, Diamant UB, Rydberg A, Persson J, Jensen SM, Stattin EL: Origin of the Swedish long QT syndrome Y111C/KCNQ1 founder mutation. Heart Rhythm. 2011, 8 (4): 541-547. 10.1016/j.hrthm.2010.11.043.CrossRefPubMed
6.
go back to reference Winbo A, Diamant UB, Stattin EL, Jensen SM, Rydberg A: Low incidence of sudden cardiac death in a Swedish Y111C type 1 long-QT syndrome population. Circ Cardiovasc Genet. 2009, 2 (6): 558-564. 10.1161/CIRCGENETICS.108.825547.CrossRefPubMed Winbo A, Diamant UB, Stattin EL, Jensen SM, Rydberg A: Low incidence of sudden cardiac death in a Swedish Y111C type 1 long-QT syndrome population. Circ Cardiovasc Genet. 2009, 2 (6): 558-564. 10.1161/CIRCGENETICS.108.825547.CrossRefPubMed
7.
go back to reference Tester DJ, Will ML, Haglund CM, Ackerman MJ: Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm. 2005, 2 (5): 507-517. 10.1016/j.hrthm.2005.01.020.CrossRefPubMed Tester DJ, Will ML, Haglund CM, Ackerman MJ: Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm. 2005, 2 (5): 507-517. 10.1016/j.hrthm.2005.01.020.CrossRefPubMed
8.
go back to reference Wei J, Fish FA, Myerburg RJ, Roden DM, George AL: Novel KCNQ1 mutations associated with recessive and dominant congenital long QT syndromes: evidence for variable hearing phenotype associated with R518X. Hum Mutat. 2000, 15 (4): 387-388.CrossRefPubMed Wei J, Fish FA, Myerburg RJ, Roden DM, George AL: Novel KCNQ1 mutations associated with recessive and dominant congenital long QT syndromes: evidence for variable hearing phenotype associated with R518X. Hum Mutat. 2000, 15 (4): 387-388.CrossRefPubMed
9.
go back to reference Berge KE, Haugaa KH, Fruh A, Anfinsen OG, Gjesdal K, Siem G, Oyen N, Greve G, Carlsson A, Rognum TO, et al: Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers. Scand J Clin Lab Invest. 2008, 68 (5): 362-368. 10.1080/00365510701765643.CrossRefPubMed Berge KE, Haugaa KH, Fruh A, Anfinsen OG, Gjesdal K, Siem G, Oyen N, Greve G, Carlsson A, Rognum TO, et al: Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers. Scand J Clin Lab Invest. 2008, 68 (5): 362-368. 10.1080/00365510701765643.CrossRefPubMed
10.
go back to reference Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G, et al: Risk stratification in the long-QT syndrome. N Engl J Med. 2003, 348 (19): 1866-1874. 10.1056/NEJMoa022147.CrossRefPubMed Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G, et al: Risk stratification in the long-QT syndrome. N Engl J Med. 2003, 348 (19): 1866-1874. 10.1056/NEJMoa022147.CrossRefPubMed
11.
go back to reference Slatkin M, Rannala B: Estimating allele age. Annu Rev Genomics Hum Genet. 2000, 1: 225-249. 10.1146/annurev.genom.1.1.225.CrossRefPubMed Slatkin M, Rannala B: Estimating allele age. Annu Rev Genomics Hum Genet. 2000, 1: 225-249. 10.1146/annurev.genom.1.1.225.CrossRefPubMed
12.
go back to reference Rannala B, Bertorelle G: Using linked markers to infer the age of a mutation. Hum Mutat. 2001, 18 (2): 87-100. 10.1002/humu.1158.CrossRefPubMed Rannala B, Bertorelle G: Using linked markers to infer the age of a mutation. Hum Mutat. 2001, 18 (2): 87-100. 10.1002/humu.1158.CrossRefPubMed
13.
go back to reference Genin E, Tullio-Pelet A, Begeot F, Lyonnet S, Abel L: Estimating the age of rare disease mutations: the example of Triple-A syndrome. J Med Genet. 2004, 41 (6): 445-449. 10.1136/jmg.2003.017962.CrossRefPubMedPubMedCentral Genin E, Tullio-Pelet A, Begeot F, Lyonnet S, Abel L: Estimating the age of rare disease mutations: the example of Triple-A syndrome. J Med Genet. 2004, 41 (6): 445-449. 10.1136/jmg.2003.017962.CrossRefPubMedPubMedCentral
14.
go back to reference Andersson P, Lundkvist L: The Q-T syndrome–a family description. Acta Med Scand. 1979, 206 (1–2): 73-76.PubMed Andersson P, Lundkvist L: The Q-T syndrome–a family description. Acta Med Scand. 1979, 206 (1–2): 73-76.PubMed
15.
go back to reference Goldenberg I, Moss AJ, Zareba W: QT interval: how to measure it and what is “normal”. J Cardiovasc Electrophysiol. 2006, 17 (3): 333-336. 10.1111/j.1540-8167.2006.00408.x.CrossRefPubMed Goldenberg I, Moss AJ, Zareba W: QT interval: how to measure it and what is “normal”. J Cardiovasc Electrophysiol. 2006, 17 (3): 333-336. 10.1111/j.1540-8167.2006.00408.x.CrossRefPubMed
16.
go back to reference Huang L, Bitner-Glindzicz M, Tranebjaerg L, Tinker A: A spectrum of functional effects for disease causing mutations in the Jervell and Lange-Nielsen syndrome. Cardiovasc Res. 2001, 51 (4): 670-680. 10.1016/S0008-6363(01)00350-9.CrossRefPubMed Huang L, Bitner-Glindzicz M, Tranebjaerg L, Tinker A: A spectrum of functional effects for disease causing mutations in the Jervell and Lange-Nielsen syndrome. Cardiovasc Res. 2001, 51 (4): 670-680. 10.1016/S0008-6363(01)00350-9.CrossRefPubMed
17.
go back to reference Wilde AA, Escande D: LQT genotype-phenotype relationships: patients and patches. Cardiovasc Res. 2001, 51 (4): 627-629. 10.1016/S0008-6363(01)00389-3.CrossRefPubMed Wilde AA, Escande D: LQT genotype-phenotype relationships: patients and patches. Cardiovasc Res. 2001, 51 (4): 627-629. 10.1016/S0008-6363(01)00389-3.CrossRefPubMed
18.
go back to reference Moss AJ, Shimizu W, Wilde AA, Towbin JA, Zareba W, Robinson JL, Qi M, Vincent GM, Ackerman MJ, Kaufman ES, et al: Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation. 2007, 115 (19): 2481-2489. 10.1161/CIRCULATIONAHA.106.665406.CrossRefPubMedPubMedCentral Moss AJ, Shimizu W, Wilde AA, Towbin JA, Zareba W, Robinson JL, Qi M, Vincent GM, Ackerman MJ, Kaufman ES, et al: Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation. 2007, 115 (19): 2481-2489. 10.1161/CIRCULATIONAHA.106.665406.CrossRefPubMedPubMedCentral
19.
go back to reference Crotti L, Spazzolini C, Schwartz PJ, Shimizu W, Denjoy I, Schulze-Bahr E, Zaklyazminskaya EV, Swan H, Ackerman MJ, Moss AJ, et al: The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. Circulation. 2007, 116 (21): 2366-2375. 10.1161/CIRCULATIONAHA.107.726950.CrossRefPubMed Crotti L, Spazzolini C, Schwartz PJ, Shimizu W, Denjoy I, Schulze-Bahr E, Zaklyazminskaya EV, Swan H, Ackerman MJ, Moss AJ, et al: The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. Circulation. 2007, 116 (21): 2366-2375. 10.1161/CIRCULATIONAHA.107.726950.CrossRefPubMed
20.
go back to reference Brink PA, Crotti L, Corfield V, Goosen A, Durrheim G, Hedley P, Heradien M, Geldenhuys G, Vanoli E, Bacchini S, et al: Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. Circulation. 2005, 112 (17): 2602-2610. 10.1161/CIRCULATIONAHA.105.572453.CrossRefPubMed Brink PA, Crotti L, Corfield V, Goosen A, Durrheim G, Hedley P, Heradien M, Geldenhuys G, Vanoli E, Bacchini S, et al: Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. Circulation. 2005, 112 (17): 2602-2610. 10.1161/CIRCULATIONAHA.105.572453.CrossRefPubMed
21.
go back to reference Tranebjaerg L, Bathen J, Tyson J, Bitner-Glindzicz M: Jervell and Lange-Nielsen syndrome: a Norwegian perspective. Am J Med Genet. 1999, 89 (3): 137-146. 10.1002/(SICI)1096-8628(19990924)89:3<137::AID-AJMG4>3.0.CO;2-C.CrossRefPubMed Tranebjaerg L, Bathen J, Tyson J, Bitner-Glindzicz M: Jervell and Lange-Nielsen syndrome: a Norwegian perspective. Am J Med Genet. 1999, 89 (3): 137-146. 10.1002/(SICI)1096-8628(19990924)89:3<137::AID-AJMG4>3.0.CO;2-C.CrossRefPubMed
22.
go back to reference Westin G, Olofsson SI: Övre Norrlands historia. D. 1, Tiden till 1600 /The History of The Upper Northern Regions. part 1, Time before 1600. 1962, Umeå: Norrbottens och Västerbottens läns landsting Westin G, Olofsson SI: Övre Norrlands historia. D. 1, Tiden till 1600 /The History of The Upper Northern Regions. part 1, Time before 1600. 1962, Umeå: Norrbottens och Västerbottens läns landsting
23.
go back to reference Einarsdottir E, Egerbladh I, Beckman L, Holmberg D, Escher SA: The genetic population structure of northern Sweden and its implications for mapping genetic diseases. Hereditas. 2007, 144 (5): 171-180. 10.1111/j.2007.0018-0661.02007.x.CrossRefPubMed Einarsdottir E, Egerbladh I, Beckman L, Holmberg D, Escher SA: The genetic population structure of northern Sweden and its implications for mapping genetic diseases. Hereditas. 2007, 144 (5): 171-180. 10.1111/j.2007.0018-0661.02007.x.CrossRefPubMed
Metadata
Title
Phenotype, origin and estimated prevalence of a common long QT syndrome mutation: a clinical, genealogical and molecular genetics study including Swedish R518X/KCNQ1families
Authors
Annika Winbo
Eva-Lena Stattin
Charlotte Nordin
Ulla-Britt Diamant
Johan Persson
Steen M Jensen
Annika Rydberg
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2014
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-14-22

Other articles of this Issue 1/2014

BMC Cardiovascular Disorders 1/2014 Go to the issue